SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-kappa B axis | |
Ma, Qiang; Wu, Xiuxiu; Wu, Jing; Liang, Zhiyong; Liu, Tonghua | |
2017 | |
卷号 | 51期号:4页码:1104-1114 |
关键词 | stress associated endoplasmic reticulum protein 1 pancreatic cancer prognostic marker SRPRB apoptosis |
ISSN号 | 1019-6439 |
DOI | 10.3892/ijo.2017.4111 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6363709 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Ma, Qiang,Wu, Xiuxiu,Wu, Jing,et al. SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-kappa B axis[J],2017,51(4):1104-1114. |
APA | Ma, Qiang,Wu, Xiuxiu,Wu, Jing,Liang, Zhiyong,&Liu, Tonghua.(2017).SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-kappa B axis.,51(4),1104-1114. |
MLA | Ma, Qiang,et al."SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-kappa B axis".51.4(2017):1104-1114. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论